Salvia Investment GmbH
SEC Form 4 insider trading activity
Salvia Investment GmbH has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Nov 2, 2026.
On the most recent filing, Salvia Investment GmbH is listed as 10% Owner at Bambusa Therapeutics, Inc. Inside the rolling window, Salvia Investment GmbH reported 1 open-market purchase totaling $6.0M in BBTX and no open-market sales.
Companies traded
Other insiders at BBTX
Insider Buying
$6.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Salvia Investment GmbH made?
Salvia Investment GmbH has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Salvia Investment GmbH trade?
Salvia Investment GmbH has filed SEC Form 4 disclosures for 1 company, including BBTX.
When was Salvia Investment GmbH's most recent SEC Form 4 filing?
Salvia Investment GmbH's most recent SEC Form 4 filing on Tracefour is dated Nov 2, 2026.
What is Salvia Investment GmbH's total buy and sell value in the current window?
Inside the rolling retention window, Salvia Investment GmbH bought $6.0M and sold $0 based on SEC Form 4 filings.
What was Salvia Investment GmbH's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 375,000 BBTX shares on 2026-11-02, worth $6.0M, per SEC Form 4 filings.